Public Charity

SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM

Based in SCHAUMBURG, IL, SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM operates as a Public Charity. The organization reported $684K in revenue, $313K in expenses, $1.8M in total assets for fiscal year 2025.

EIN: 262943602 SCHAUMBURG, IL Cancer Research NTEE: H30 Latest filing: 2025

Total Revenue$684K

Total Expenses$313K

Total Assets$1.8M

Grant Records0

Filing Years2021–2025

Mission

THE SOCIETY IS A NATIONAL ALLIANCE OF LEADING ACADEMIC AND COMMUNITY BASED URO-ONCOLOGISTS COMMITTED TO THE FOLLOWING - TO FURTHER UROLOGY RESEARCH AND PHARMACEUTICAL TRIALS, - TO OFFER & PROVIDE FOR THE BEST POSSIBLE APPROACH TO DISEASE EDUCATION AND MANAGEMENT PROVIDING FOR BETTER PATIENT OUTCOMES, - TO PROVIDE EDUCATION FOR THE PROFESSION TO FURTHER THE LEARNINGS CONDUCTED THROUGH THE PROFESSION, - AND TO ALLOW CLINICIANS TO BE AWARE OF EXISTING RESEARCH, WHICH ADVANCES FURTHER CLINICAL EDUCATION AND HYPOTHESES.

Where $100 goes at Society of Urologic Oncology Clinical Trials Consortium

How Society of Urologic Oncology Clinical Trials Consortium divides every $100 it spends, from its own Form 990 filings, averaged across 9 years.

$78 Programs the work itself

$22 Management running the organization

$0 Fundraising none reported

No fundraising costs are reported. That often means fundraising runs through a separate affiliated organization that files its own return.

Inside the $78 for programs

$78

The consortium assists doctors and hospitals conducting clinical trials with expedited concept and protocol review, standardized protocol and contract language, and centralized data management to help test needed…

All program spending

Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.

Officers & Directors

Director Adam Stuart Kibel Md

Treasurer Brian Matthew Shuch Md

Director Daniel W Lin Md

PAST PRESIDENT Gennady Bratslavsky Md

Director Kirsten Lynn Greene Md Ms

Executive Dir. Ms Pam Murphy

Officer compensation and complete director data available with membership.

Financial Trends

Year	Revenue	Expenses	Assets
2025	$684K	$313K	$1.8M
2024	$554K	$270K	$1.4M
2023	$332K	$238K	$1.1M
2022	$627K	$184K	$1.0M
2021	$220K	$154K	$561K

Between 2021 and 2025, reported annual revenue grew from $220K to $684K (+212%), with total assets most recently reported at $1.8M.

Interactive year-over-year charts and full filing details available with membership.

See the full picture for SOCIETY OF UROLOGIC ONCOLOGY CLINICAL TRIALS CONSORTIUM

Complete financials, all 0 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 880,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports